Christopher Fraser,Takashi Kei Kishimoto,Roberto A. Maldonado
申请号：
US16536154
公开号：
US20200101154A1
申请日:
2019.08.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed are synthetic nanocarrier methods, and related compositions, comprising administering immunosuppressants and MHC Class I-restricted and/or MHC Class II-restricted epitopes that can generate tolerogenic immune responses (e.g., antigen-specific T effector cell deletion).
